ITGB4 and ovarian carcinoma: For example, in ovarian cancer cells, Spectrin beta non-erythrocytic 2 (SPTBN2) may promote tumor migration and invasion by inhibiting the expression of focal adhesion-related proteins and downstream signaling pathways via ITGB4.